Endovascular treatment of haemoptysis: Medium and long-term assessment

Abstract

BAE is an effective treatment. Aspergilloma is a major risk factor in the recurrence of haemoptysis. Repeated embolisation may be proposed for these patients.

A retrospective analysis of 334 cases of hemoptysis treated by bronchial artery embolization

“…However, increasingly it is used in moderate hemoptysis and recurrent mild hemoptysis that hampers the lifestyle of the patient. 9,10,16,17 The majority of our patients (58.4%) had moderate hemoptysis. Recurrent mild hemoptysis was present in 21% of patients and the rest had severe hemoptysis.…”

“…This can be attributed to the increasing use of microcatheters as has been mentioned in recent studies. [8][9][10][11][12][13] With microcatheters, it is now possible to safely deliver the embolization material beyond the origin of the spinal arteries thus preventing this complication. We encountered only minor complications such as non-progressive localized dissection and chest pain.…”

“…This result is comparable to results of previous studies. [8][9][10][11]18 Repeat procedure within two months was performed in 25 (6.5%) patients due to technical or clinical failure of the procedure. This might be because of failure to identify or embolize bleeding vessels in the first setting or the nature of primary disease not responding to bronchial artery embolization.…”

“…The value of BAE in controlling massive hemoptysis is well documented. [8][9][10][11][12][13] In this retrospective analysis we sought to analyze the safety, technical success, and short and long-term outcomes of BAE.…”

Bronchial Artery Embolisation in Massive Haemoptysis

“…Similarly, a study by Racil et al reported the short (< 30 days) and medium-term (> 30 days and < 3 years) recurrence rate of haemoptysis was 17.39% and 8.69% respectively after BAE in 53 consecutive patients. 15 The 50% episodes of short-term recurrences were related to aspergilloma and 80% of the patients with aspergilloma had short-term recurrence. The long-term recurrence (>3 years) of haemoptysis was also related to aspergilloma.…”